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ABSTRACT
Aims: To synthesize small molecule alkylating compounds and analyze the kinetics of the
alkylation in aqueous solution. Determine molecular properties and the drug likeness of these four
compounds as potential antineoplastic agents and apply statistical analysis to identify
interrelationships of properties.
Study Design: Four compounds were synthesized, characterized, and studied for alkylation
capability. The alkylation kinetics were elucidated, as well as drug likeness properties. The
interrelationships of properties were examined by statistical methodology.
Place and Duration of Study: Department of Chemistry, Durham Science Center, University of
Nebraska at Omaha, Omaha NE, from May 2015 to June 2015.
Methodology: Four compounds were modified by the covalent bonding of an alkyl halide
substituent or nitrogen mustard group. The four compounds were placed in aqueous solution at pH
7.4 and 37°C to monitor alkylation efficiency that targeted p-chloroaniline. Alkylation was monitored
utilizing fluorescamine and measurement at 400 nm. Time and absorbance plots determined
whether alkylation step is first-order or second-order. Molecular properties Log P, formula weight,
_____________________________________________________________________________________________________
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polar surface area, etc., were determined. Statistical analysis and path analysis revealed which
molecular property was most responsible for rate constant values.
Results: Compounds A, B, C, and D showed ranges of Log P, formula weight, and polar surface
area of 0.010 to 4.21, 177.59 to 714.77, and 29.64 to 88.63, respectively. All compounds showed a
favorable drug likeness, with only compound C showing a violation of the Rule of 5. The Log P
values and number of alkylation reactive sites were most responsible for rate constant value.
Conclusion: Small molecule alkylating agents are synthesized, the efficiency of alkylation
measured in aqueous solution utilizing fluorescamine at pH 7.4 and 37°C. Rate-order of reactions
is determined utilizing fluorescamine assay for surviving primary amine groups. The four
compounds showed a favorable drug likeness based on molecular properties.

Keywords: Antineoplastic; nitrogen mustard; alkylating; cancer.

ABBREVIATIONS
Term: PC, path coefficient; GPCR, G protein–coupled receptors.
antineoplastic agents is the elimination of cancer
cells without affecting normal tissue [1].

1. INTRODUCTION
Alkylating agents are a class of anticancer drugs
that directly damage DNA to prevent the cancer
cell from undergoing division [1]. A rapidly
dividing cell is most susceptible to the effects of
alkylating agents, which in their action to produce
a cross-linking of DNA either intra-strand or interstrand [1]. Nitrogen mustard drugs are an
alkylating agent that can cyclize in an aqueous
environment to form highly electrophilic
immonium ions that can covalently bind to the
nucleophilic N-7 nitrogen position on guanine [1].
Examples of alkylating agents are busulfan
(utilized for treating chronic myelogenous
leukemia), cyclophosphamide (utilized for
treating non-Hodgkin’s lymphoma, leukemias,
ovarian cancer, and breast cancer), and
mechlorethamine (utilized for treating Hodgkin’s
disease) [1]. Monoalkylating agents can react
with only one N-7 of a guanine molecule [1].

Alkylating agents can cross link with carboxyl,
hydroxyl, amino, sulfhydryl, and phosphate
groups of bio-macromolecules [5]. This action
cause abnormal base paring or scission of the
DNA strand [5]. The kill rate of cancer cells can
be enhanced with intensive/more frequent
treatment or surgical removal with chemotherapy
[1].
In the case of alkylating agents targeting DNA at
physiological pH, the most reactive nucleophilic
sites are N-7 of guanine > N-3 of adenine > N-1
of adenine > N-1 of cytosine [5]. Alkylating
agents such as nitrogen mustards are able to
undergo either SN1 (unimolecular) or SN2
(bimolecular) type reactions depending on the
rate of aziridinium ion (a positive charged ring)
formation [5].
Further studies of the alkylation agents will
improve effectiveness and clinical outcome for
cancer patients. The knowledge of the
mechanism of action can enhance understanding
of the type of alkylating antineoplastic agents
more suitable for specific cancer cases. This
study presents four novel alkylating agents, with
the characterization of the kinetics of reaction
with a targeted nucleophilic amine group.

Classical alkylating agents include melphalan,
chlorambucil, nitrogen mustards, nitrosoureas,
and alkyl sulfonates [2,3]. In general, anticancer
drugs can be classified by the mechanism of
action, the groups as follows [1]: Alkylating
agents (damage done during S phase or
doubling of chromosomal material), heavy metals
(e.g. platinum agents), antimetabolites, folic acid
antagonists, pyrimidine analogues, purine
analogues, cytotoxic antibiotics, spindle poisons
(e.g. toxoids), and topoisomerase inhibitors.
Additional clinical studies have shown a revived
application for alkylating agents. A notable
example is an improved outcome/treatment
found with chlorambucil treatment of chronic
lymphocytic leukemia [4]. The clinical purpose of

2. METHODOLOGY
2.1 Chemicals and Instrumentation
Reagents utilized for the study were of HPLC
grade and obtained from Aldrich Company
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(Aldrich, PO Box 2060, Milwaukee WI 53201).
Infrared spectra were obtained from a Mattson
Galaxy FTIR in dimethyl-sulfoxide that was
previously dried over molecular sieves. The
visible wavelength spectroscopy for kinetics was
accomplished
utilizing
Spectronic
21-D
instrument with glass cuvettes. For controlled
temperature monitoring of alkylation reaction
required for rate-order determination a THELCO
Model 84 controlled water bath was utilized
(Precision Scientific Company, Chicago Illinois
60647 USA).

ring-1750 to 1800 cm (beta-lactam strained
ring); Alkyl halogen 720 cm-1 (C-Cl). For carbon13 assignments in sequence (ppm): 22.7, 44.6,
50.9, 69.5, 172.0, and 174.4.
2.3.2 Synthesis
of
D-alanine
mustard compound (B)

nitrogen

Place 0.00337 moles (0.300 g) of D-alanine into
40 mL acetonitrile which has been dried over
molecular sieves (3 Angstroms). Bubble
ammonia gas (NH3) through the mixture for 30
minutes, then degas with nitrogen flow for at
least 30 minutes to remove residual ammonia.
Add ½ volume in 1,2-dichloroethane and reflux
mildly for 2 to 3 hours. Precipitate product at 10°C overnight, filter out by vacuum filtration,
and wash with -10°C diethylether. Keep dry and
store over desiccant at -10°C.

2.2 Software, Programs, and Molecular
Modeling
The molecular properties of these study
compounds were determined by utilizing
Molinspiration
informatics
(Molinspiration
Cheminformatics, Nova ulica, SK-900 26
Slovensky Grob, Slovak Republic), ChemSketch
version 12.01 (copyright 1994-2009, ACD, 90
Adelaide Street West, Toronto Ontario, M5H3V9
Canada),
and
ALOGPS
software
[6].
Calculation of water solubility was completed
with EPISUITE version 1.66 (Copyright 2000,
U.S.
Environmental
Protection
Agency,
Washington DC). Summary statistics was
performed by PAST Version 0.45 (Copyright
Oyvind Hammer, 2001) [7] and Microsoft EXCEL
2013 from Microsoft Office Professional plus
2013. Bioactivity scores for compounds were
determined by Molinspiration Cheminformatics.
For outliers, Grubb’s test was applied
with
online
QuickCalcs
Graphpad
(http://www.graphpad.com/quickcalcs/).

Infrared analysis of Compound (B): For ester
-1
group 1700 cm (C=O stretch); C-N 1350-1000
-1
cm ; tertiary amine group-1200 cm-1 (C-N
-1
stretch); Alkyl halogen-720 cm (C-Cl); C-H 3000
-1
cm (broad). For carbon-13 assignments in
sequence (ppm): 14.9, 44.6, 44.7, 53.1, 59.0,
69.5, 172.0.
2.3.3 Synthesis of compound (C)
Place 0.00260 moles (0.500 grams) of citric acid
into 50.0 mL of acetonitrile dried over molecular
sieves. Add 2.0 mL of thionyl chloride and reflux
for 2 hours. Remove excess thionyl chloride by
distillation and adding additional acetonitrile to
maintain volume. Cool, then add 0.3 mL of
triethylamine
with
0.0156
moles
of
triethanolamine (which has been dissolved in
minimal dry acetonitrile previously). Reflux mildly
for 1 hours.
Precipitate product at -10°C
overnight, then vacuum filter to isolate product.
Wash with -10°C diethyl ether, store the ester of
citric acid dry at -10°C. Then place 0.00130
moles of ester of citric acid into 50.0 mL of dry
acetonitrile, followed by 5.0 mL of triethylamine.
Slowly add 0.00130 moles of thionyl chloride,
reflux mildly for 1 hour to 2 hours. Precipitate
final product at -10°C overnight, then vacuum
filter out the final product. Wash with -10°C
acetone, store dry at -10°C.

2.3 Synthesis of Alkylating Compounds
2.3.1 Synthesis of compound (A)
Place 0.000652 moles (0.0750 grams) of (S)-(-)4-oxo-2-azetidine carboxylic acid into 50.0 mL of
acetone that is previously dried over molecular
sieves. Force ammonia (NH3) gas through the
mixture for 2 hours then degas with nitrogen flow
to remove the residual ammonia. Add 20x
excess by moles of ClCH2CH2Cl and reflux (mild)
for 1 hour. Precipitate the product at -10°C
overnight, then filter out by vacuum filtration.
Wash with -10°C diethyl ether and the product
can be store dry at -10°C.

Infrared analysis of Compound (C): For ester
group 1700 cm-1 (C=O stretch); C-H 3000 cm-1
-1
(broad); C-Cl aliphatic halogen 705 cm ; tertiary
-1
amine group 1180 cm (C-N stretch); C-N 13501000 cm-1. For carbon-13 assignments in

Infrared analysis of Compound (A) : For C-N,
1350-1000 cm-1; C=O, 1700 cm-1; C-H 3000 cm-1
-1
(broad); N-H 3300 cm (broad); Beta-lactam
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sequence (ppm): 39.3, 44.7, 52.2, 55.1, 55.9,
66.2, 66.4, 166.4, and 172.0.

compound and p-chloroaniline). At known time
periods withdraw 50 microliters of reaction
mixture and place into a glass cuvette, add 50
microliters of fluorescamine (that is 5 mg/mL in
methanol), mix well, then add distilled water to
3.00 milliliters total volume. The mixtures should
be analyzed by spectrometer quickly, and not
stored for later use.

2.3.4 Synthesis of octyl methanesulfonate
compound (D)
Place 0.0312 moles (3.00 grams) of
methanesulfonic acid into 50 mL of acetonitrile
dried over molecular sieves (3 Angstroms size of
sieve). Add 3 to 5 mL of thionyl chloride into this
mixture and reflux for 2 to 3 hours. Distill out
excess thionyl chloride while adding additional
acetonitrile to maintain volume. Add 0.03590
moles of 1-octanol, 0.1 milliliter of triethylamine,
and reflux (mild) for 2 to 3 hours. Distill out
solvent to reduce volume and precipitate product
at -10°C overnight. Carefully remove supernatant
from product and wash several times with -10°C
diethyl ether, remove ether supernatant wash
from product by vacuum if necessary. The
product must be kept dry and store at -10°C until
use.

Absorbance of mixtures are read at 400
nanometers wavelength with suitable visible
wavelength spectrophotometer (Spec 21 with 1
cm glass cuvettes for this study). To determine
the best fit for rate-order of kinetics plot the
absorbance data is considered the dependent
variable and the time the sample aliquot is
withdrawn from the reaction solution is the
independent variable. For first-order considered
then plot time (independent variable) versus Ln
(absorbance). For second-order consideration
then plot 1/absorbance versus time. For zero
order consideration then plot raw absorbance
(dependent variable) versus time.

Infrared analysis of Compound (D): For
-1
methanesulfonate group 1350-1300 cm (S=O);
-1
C-O 1300-1000 cm (stretch); C(S=O)-C 1050
-1
-1
cm ; (-CH2-O-S-) group- 950 to 1075 cm ; C-H
-1
3000 cm (broad). For carbon-13 assignments in
sequence (ppm): 14.0, 23.1, 26.2, 30.0, 30.3,
30.7, 32.5, 53.9, and 72.4.

3. RESULTS AND DISCUSSION
Evaluations of the overall clinical cancer
treatment outcome have concluded that many
common cancers are not adequately treated by
present-day chemotherapy [8]. Crucial is the
need for novel drugs to treat childhood cancers
and the mechanisms by which the clinical trials
can be efficiently conducted [9]. Lead
modification of alkylating agents has been
consistently shown to be advantageous for this
class of anticancer drugs, and has led to
expansion of their clinical application [5]. The
four compounds presented here demonstrate the
potential of covalently bonding alkylation groups
onto known functional molecular scaffolding and
the measurement of actual alkylating activity to
include rate-order determination. The four
alkylating compounds presented in Fig. 1, are
studied to show alkylation of a primary amine
nucleophile (p-chloroaniline), determination of
rate-constants, and molecular properties.

2.4 Measurement and Determination of
Rate-Order and Rate Constants
Fluorescamine solution: A stock solution of
fluorescamine is made new before each
spectroscopy determination. This reagent is
made
to
a
concentration
of
5.0
milligrams/milliliter of methanol. For 25 milliliters,
dissolve 125 milligrams of fluorescamine into 25
milliliters of methanol.
Buffer solution with p-chloroaniline: Into a
previous prepared aqueous pH 7.4, 0.100 molar
NaHCO3 buffer dissolve one milligram of pchloroaniline per milliliter. This mixture should be
made up fresh prior to use.

The reaction order for nucleophilic substitution
depends on the chemical structure of the
alkylating agent [5]. An alkylation reaction can
proceed by SN1 or SN2 mechanisms [5,10].

Analysis for Rate-Order of Reaction and Rate
Constant: Pre-warm a volume of 1.00 milliliter of
aqueous pH 7.4, 0.100 molar NaHCO3 that also
contains 1.0 milligram of p-chloroaniline. Place
25.0 milligrams of the alkylating compound to be
tested into this volume of aqueous buffer and
keep at 37°C with the water bath. Start time
monitor upon addition of reactant (alkylating

Compound A begins with 4-oxoazetidine-2carboxylic acid that is modified by emplacement
of –OCH2CH2Cl substituent upon the former
carboxyl group (-COOH). The result is an agent
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having one site of alkylation. Following with
compound B, the resulting structure has
potentially three sites of alkylation, to include the
nitrogen mustard group (-N(CH2CH2Cl)2).

Compound C begins with citric acid (C6H8O7, 2hydroxypropane-1, 2, 3-trioic acid) that continues
to finally having three nitrogen mustard groups
with a potential of six alkylation sites. Compound
D, beginning with 1-octanol, has a single
methane sulfonate group allowing one alkylation
site.

O

H
N

A
O

O

The molecular properties of compounds A, B, C,
and D are shown in Table 1. Various molecular
properties are known to substantially affect the
drug-likeness of a compound, the polar surface
area has been shown to be useful in predicting
intestinal absorption [11]. Fast and reliable
estimation of intestinal absorption can be
achieved by determination of polar surface area
[11]. Based on polar surface area values for A, B,
C, and D, the expected level of intestinal
absorption for drug amount present following oral
administration would be 89%, 99%, 48%, and
97%, respectively.

Cl

O
H3C

Cl
O

B

N

Cl

Cl

Although substantially different in molecular
structure, the property numerical values for all
four compounds given in Fig. 1 have very strong
positive correlation with Pearson r correlation for
all four compounds is greater than 0.9900 (very
strong positive correlation is r > 0.7000).

Cl

Cl

Cl
N
N

O
O

Cl

C

O

One-way ANOVA testing of the Table 1
properties indicates that the mean of the
summed values are equal (P=0.38) [12]. In
addition, by the Kruskal-Wallis test there is no
significant difference between sample medians
(P= 0.86). An interesting finding for these
alkylating compounds of different structures.

Cl
O

O
O
Cl
N

Following with the Grubb’s test for outliers (alpha
= 0.05) [12], notably there are no outliers for
numerical values of formula weight, number of
oxygen & nitrogen atoms, polar surface area,
molecular volume, and Log P. The solubility
indicated in mole per liter has a strong negative
correlation with a formula weight (Pearson
correlation r = -0.4505) and molecular volume
(Pearson correlation r = -0.5005). That is, as
molecular weight and molecular volume
increases, the solubility of the compound
decreases. This is consistent with previous
studies of drug-likeness where drug solubility in
general is shown to decrease with increase of
molecular size [13].

Cl

D

O
H3C

O
S
O

CH3

Fig. 1. Molecular structures of four alkylating
compounds. Compound A (2-chloroethyl 4oxoazetidine-2-carboxylate) has one potential
alkylating site; Compound B (2-chloroethyl 2[bis(2-chloroethyl)amino]propanoate) has
three potential alkylating sites; Compound C
(1,2,3-({2-[bis(2chloroethyl)amino]ethoxy}carbonyl)-2chloropropane) has 6 potential alkylating
sites; and compound D (octyl
methanesulfonate) has one potential
alkylating site

The Rule of five, also known as the Pfizer's rule
of five, is a set of parameters to evaluate druglikeness and to determine if a chemical
compound with a certain pharmacological or
70
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Table 1. Properties of compounds
Property
Log P
Polar surface area
(Angstroms2)
Number of atoms
Formula weight
grams/mole
Number of oxygen & nitrogen
atoms
Number of –OH & -NHn
Violations of the rule of 5
Number of rotatable bonds
Molecular volume
3
(Angstroms )
Solubility
(mole/Liter)

Compound A
0.010
55.40

Compound B
2.35
29.54

Compound C Compound D
4.21
3.13
88.63
43.38

11
177.59

15
276.59

40
714.77

13
208.32

4

3

9

3

1
0
4
141.92

0
0
9
228.19

0
1
29
582.18

0
0
8
203.79

0.295

5.01E-03

6.31E-07

6.17E-04

biological activity has properties that would make
it a likely orally active drug in humans [14]. In
general, when considering potentially useful
compounds for medicinal purposes, then an
orally active drug has no more than one violation
of the following criteria [14]:

desired properties [14,15]. Biological activity or
pharmacological activity, describes the beneficial
or adverse effects of a drug on target tissues.
Generally, an activity is considered to be dosedependent and a compound is considered
bioactive if it has interacted with or effect on a
target tissue of the human body. By use of
Bayesian statistics the four compounds were
compared to six highly important drug classes to
determine bioactivity scores (see Table 2). With
respect to drug-likeness for the classes of GPCR
ligand, ion channel modulator, and kinase
inhibitor the range of drug-lilke compounds are: 1.50 to 0.50, -2.0 to 0.5, and -1.8 to 0.5,
respectively. Note that all four compounds A, B,
C, and D have scores that fall within the
prospective ranges for identification as drug-like
compounds. For the classes of nuclear receptor
ligand, protease inhibitor, and enzyme inhibitor,
the criteria range of score for drug-like
compounds are: -2.0 to 0.5, -1.7 to 0.5, and -1.5
to 0.5, respectively. Note that all four compounds
A, B, C, and D have scores that fall within the
perspective ranges for drug-like compounds.
These results support the beneficial potential of
these four compounds. All four compounds have
bioactivity scores within the drug-like region for
all six important classes of drugs. The molecular
structures of the four compounds substantially
differ. One-way ANOVA analysis of Table 2
values indicates that the means of the
scores determined for A, B, C, and D are not
equal (P= 0.000139).

A. No more than 5 hydrogen bond donors
(total number of –NHn and -OH)
B. Not more than 10 hydrogen bond
acceptors (all nitrogen or oxygen atoms)
C. A molecular mass less than 500 Daltons
D. An octanol-water partition coefficient log P
not greater than 5
Shown in Table 1, compounds A, B, and D has
zero violations of Rule of 5, while compound C
has only one violation. Essentially, by this
criteria, all compounds are considered to have
suitable
oral
activity
capability.
These
compounds show a favorable drug-likeness. In
addition, previous studies have shown that orally
active drugs having polar surface area less than
2
120 Angstroms are suitable for passive
transport by the transcellular route [15], which is
a criteria compounds A, B, C, and D fulfill. A drug
having polar surface area less than 60
2
Angstroms are able to penetrate through the
brain-blood barrier and into the brain. By this
criteria, compounds A, B, and D are suitable for
penetrating into the brain.
It is beneficial to have tools to predict and
discriminate the pharmacological activity of a
given molecular compound so that the study is
directed to molecular groups where there is a
high probability of finding new compounds with

For determination of rate-order and rate
constants of alkylation reactions, the compounds
were placed into buffered aqueous solutions at
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physiological pH 7.4 and 37°C. The target of
alkylation is the nucleophilic amine group (-NH2)
of p-chloroaniline. An alkylation reaction of pchloroaniline with any of the four compounds will
eliminate the primary amine group. The
presence, and change in concentration of the
primary amine group –NH2 can be accurately
assayed
by
use
of
fluorescamine.
Fluorescamine itself is a spiro compound that
does not fluorescent itself, but reacts with
primary amines to form a highly fluorescent
product. By this means, it has been used as a
reagent for the detection of amines and peptides
[16]. The reaction of compound A with pchloroaniline is shown in Fig. 2.

Note that the Pearson correlation coefficient for
compound A second-order plot, is r = 0.9947
(extremely high positive correlation). With the
Pearson correlation coefficient for compound C
first-order plot being r = 0.9399 (very strong
positive correlation is r > 0.7000).
The reaction order with rate constants for
compounds A, B, C, and D are presented in
Table 3 for comparison to the number of
alkylation sites, formula weight, polar surface
area, and Log P. The Grubb’s test indicated that
there were no outliers among the numerical
values of the rate constants.
There is a strong negative relationship of rate
constants values to polar surface area (Pearson
r= -0.5027) and to Log P (Pearson r = -0.5149)
(strong negative correlation is r from -0.4000 to 0.6900). There is a very strong positive
relationship of number of alkylation sites to
formula weight (Pearson r = 0.9672), but strong
positive relationship to polar surface area
(Pearson r = 0.6849) and Log P (Pearson r =
0.6949) (strong positive correlation is r from
0.4000
to
0.6900).
This
suggests
interrelationship of rate of reaction to the
physiochemical properties of the alkylating
compounds.

In the reaction solutions, after alkylation, there is
left remaining unreacted p-chloroaniline which
can be assayed by the highly specific
fluorescamine derivatization of the primary amine
group and detection at 400 nm wavelength
[17,18]. Removing of aliquots at known time and
assay at 400 nm allows the monitoring of the
course of the alkylation reaction (by a monitor of
un-reacted p-chloroaniline). By this approach the
elucidation for rate-order of the reaction and the
rate constants can be determined. Two examples
of these plots, one for second-order (compound
A) and one for first-order (compound C) are
presented in Fig. 3.

Table 2. Bioactivity scores for compounds
Biological activity
GPCR ligand
Ion channel modulator
Kinase inhibitor
Nuclear receptor ligand
Protease inhibitor
Enzyme inhibitor

Compound A
-1.07
-0.79
-1.37
-1.53
-0.93
-0.86

Compound B
-0.80
-0.54
-0.75
-1.00
-0.70
-0.61

Compound C
-0.13
-0.48
-0.17
-0.13
-0.08
-0.015

Compound C
-0.56
-0.66
-0.95
-0.50
-0.39
0.34

Table 3. Rate of reaction and rate constant comparison
Drug

Formula
weight
(grams/mole)
177.59

Polar
surface
area (A2)
55.40

Log P

Reaction order
rate constant

Compound A

Number of
sites of
alkylation
1

0.010

Compound B

3

276.59

29.54

2.35

Compound C

6

714.77

88.63

4.21

Compound D

1

208.32

43.38

3.13

Second order
0.0184 molar-1 minute-1
First order
0.0258 minute-1
First order
0.00997 minute-1
First order
-1
0.00594 minute
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Cl
NH2

O

O

H
N

O

HN

+

O

NH
O
Cl

Cl
O

Fig. 2. Example alkylation reaction of compound A with target p-chloroaniline. The primary
amine group of p-chloroaniline is eliminated

Fig. 3. Example plots for rate-order analysis, for compound A (top) and compound C (bottom).
The pearson correlation coefficient for compound A second-order plot, is
r = 0.9947 (very strong high positive correlation is r > 0.7000). The pearson correlation
coefficient for first-order plot of compound C is a very strong positive correlation r = 0.9399
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Further explanation for the causality of the rate of
reactions can be determined by use of path
analysis. Path analysis is an extension of
multiple regression with the aim to provide
estimates of the magnitude and significance of
hypothesized causal connections between sets
of variables [19]. Path analysis is a form of
statistical analysis used to evaluate causal
models by examining the relationships between a
dependent variable and two or more independent
variables. There are two main requirements for
path analysis [19]: 1) All causal relationships
between variables must go in one direction only
(i.e. a pair of variables cannot cause each other);
2). The variables must have a clear time-ordering
since one variable cannot be said to cause
another unless it precedes it in time.

apply path analysis to elucidate which of the
important molecular properties formula weight,
polar surface area, Log P, or number of
alkylation sites can be identified as causative
variable(s) for rate of reaction. The larger the
path coefficient, the greater the proposed
causative relationship between variables [19,20].
The path diagram outcome of path analysis of
Table 3 is presented in Fig. 4. The parameters of
the path analysis evaluated the causality of each
property as stand-alone to actual rate constants
(or the rate of reaction). A striking result is
observed, and that is the importance of each
property for the measured rate of reaction.
Essentially, Log P is found to have great
influence (PC = 0.629), followed by number of
alkylation sites (PC = 0.435). These two
properties exert highest influence, but are
followed by the formula weight (PC = 0.351) and
polar surface area (PC = 0.261). This provides a
means to understand the rate of alkylation of a
nucleophile and how that rate is influenced.

Representation of results of path analysis is
achieved by considering a path diagram, which
presents the names of the variables and draws
arrows from each variable to any other variable
we believe that it affects. Associated with the
arrows are path coefficients (PC) that are
standardized versions of linear regression
weights used to examine the possible causal
linkage between variables in the modeling
approach [19,20].

The four compounds A, B, C, and D have been
shown to efficiently alkylate a nucleophilic
primary
amine
group.
All
compounds
demonstrated favorable drug-likeness and for
compounds A, B, and D have the favorable
potential of penetrating through the blood-brain
barrier, as a consequence of the low polar
surface area.

The rate constants for alkylation reaction of
compounds A, B, C, and D with a nucleophile is
shown in Table 3. An interesting inquiry is to

Fig. 4. Path diagrams show variables interconnected and specify causal flow. A path
coefficient in this model clearly shows that the casual relationship of property to rate constant
values has the following order: Log P (0.629) > number of alkylation sites (0.435) > formula
weight (0.351) > polar surface area (0.261)
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The study, synthesis, and examination of novel
alkylating agents is a very necessary endeavor in
the pursuit of useful medicaments for clinical
treatment of neoplastic diseases. In this study,
four compounds were formed by emplacement of
functional groups known to effectuate an
alkylation reactivity. The requirement for
successful kinetics analysis is that it is imperative
to monitor the reaction's progress by following
the change in concentration for at least one of its
species. These four compounds are successful
alkylating agents and have been characterized to
authenticate
the
favorable
potential
as
antineoplastic drugs.
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